US Department of Defense – Neurofibromatosis Research Program (NFRP) – Early Investigator Research Award
Sponsor: US Department of Defense
Closing Date: 26-Jul-2018
The Neurofibromatosis Research Program seeks to support innovative, high-impact research that will foster new directions for and address neglected issues in neurofibromatosis (NF) research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; promote translational and clinical studies to move promising ideas from bench to bedside; and develop a balanced portfolio of meritorious research related to all aspects of NF type 1 (NF1) and type 2 (NF2), and schwannomatosis. The FY18 NFRP strongly encourages research applications that specifically address the critical needs of the NF community in one or more of the Areas of Emphasis.

The Early Investigator Research Award supports NF-focused research opportunities for individuals in the early stages of their careers, under the guidance of a designated Mentor. This opportunity allows for early stage investigators to develop a research project, investigate a problem or question in NF research, and further their intellectual development as an NF researcher of the future. The postdoctoral investigator is considered the Principal Investigator (PI) of the application and must exhibit strong potential for, and commitment to, pursuing a career as an investigator at the forefront of NF research; however, the PI is not required to have previous NF research experience.

The investigator must:
• Be involved in a postdoctoral training or medical residency program; and
• Possess at least 1 and up to 4 years of continuous postdoctoral research experience by 1 June 2018; and
• Possess a doctoral degree (i.e., Ph.D., MD/Ph.D., DO/Ph.D.) or a clinical doctoral degree (i.e., MD/DO or Ph.D. in a clinical discipline) from an accredited organization or program.

Key Mechanism Elements
• Supports NF-focused research opportunities for individuals in the early stages of their careers.
• Investigators must have a designated mentor who is an experienced NF researcher.
• Applications must include at least one Mentor, appropriate to the proposed research project, who has experience in NF research and mentoring as demonstrated by a record of active funding, recent publications, and successful mentorship.
• Clinical trials are not allowed.

• Maximum funding of USD $200,000 for direct costs (plus indirect costs).
• Maximum period of performance is 2 years.

Please see the U.S. Department of Defense Congressionally Directed Medical Research Program (CDMRP) website at and for further information. Pre-applications are submitted via the CDMRP’s Electronic Biomedical Research Application Portal (EBRAP) and full applications are submitted via For complete instructions for pre-applications and full applications, you must refer to both the Program Announcement and General Application Instructions documents.

Key Dates
Full applications due to UQR&I:
19 July 2018
Pre-applications (mandatory) close with US Department of Defense: 26 July 2018
Full applications close with US Department of Defense: 9 August 2018
Confidential Letters of Recommendation due to US Department of Defense: 14 August 2018

Ahead of internal review, ensure all online components on EBRAP or are complete. To initiate review, email your completed Funding Application Coversheet to Interested applicants are strongly encouraged to make contact with the UQR&I international team (via well in advance of the UQR&I internal deadline to discuss their application.